Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol

Detalhes bibliográficos
Autor(a) principal: Kraychete, Durval Campos
Data de Publicação: 2009
Outros Autores: Sakata, Rioko Kimiko [UNIFESP], Issy, Adriana Machado [UNIFESP], Bacellar, Olívia, Jesus, Rogério Santos, Carvalho, Edgar M
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S0034-70942009000300004
http://repositorio.unifesp.br/handle/11600/5073
Resumo: BACKGROUND AND METHODS: Proinflammatory cytokines play an important role in the pathophysiology of neuropathic pain syndromes. The objective of this study was to evaluate plasma levels of proinflammatory cytokines before and after treatment with tramadol in patients with herniated intervertebral disks and carpal tunnel syndrome, and to compare them with normal individuals. METHODS: Thirty-eight patients with neuropathic pain secondary to herniated intervertebral disks or carpal tunnel syndrome participated in this study. All patients were treated with controlled release tramadol (100 mg every 12 hours) for 10 days. Venous blood (5 mL) was collected in the morning, before treatment and on the 11th day, and stored (-70° C) until analysis. ELISA was used to determine the plasma levels of cytokines (TNF-±, IL-1, IL-6) and receptors sTNF-R1 (R & D Systems). Plasma levels of cytokines of 10 healthy volunteers were also determined. RESULTS: The concentration of TNF-± before (5.8 ± 2.8 pg.mL-¹) was significantly higher than after treatment with tramadol (4.8 ± 2.1 pg.mL-1; p = 0.04, Mann-Whitney test). The levels of IL-1², IL-6, and sTNF-R1 before and after treatment with tramadol showed no significant differences. Plasma levels of TNF-± (healthy individuals: 1.4 ± 0.5; pain patients: 5.8 ± 2.8 pg.mL-1; p = 0.01) and IL-6 (healthy individuals: 1.2 ± 0.8; pain patients: 3.5 ± 2.6 pg.mL-1; p = 0.01) were significantly higher in patients with neuropathic pain, Mann-Whitney Test. CONCLUSIONS: In patients with herniated intervertebral disks and carpal tunnel syndrome, plasma levels of TNF-± and IL-6 were higher than in healthy volunteers, while differences in the concentrations of sTNF-R and IL-1² were not observed. Plasma levels of TNF-±, but not of IL-6, sTNF-R, and IL-1², decreased after treatment with tramadol (100 mg every 12 hours).
id UFSP_b215e9c43526bd68f2cd9c1acf3ff73a
oai_identifier_str oai:repositorio.unifesp.br/:11600/5073
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com TramadolProinflammatory cytokines in patients with neuropathic pain treated with TramadolInterleucinas proinflamatorias en pacientes con dolor neuropático sometidos a tratamiento con TramadolANALGESICCYTOKINESPAIN, neuropathicANALGÉSICOCITOCINASDOR, neuropáticaBACKGROUND AND METHODS: Proinflammatory cytokines play an important role in the pathophysiology of neuropathic pain syndromes. The objective of this study was to evaluate plasma levels of proinflammatory cytokines before and after treatment with tramadol in patients with herniated intervertebral disks and carpal tunnel syndrome, and to compare them with normal individuals. METHODS: Thirty-eight patients with neuropathic pain secondary to herniated intervertebral disks or carpal tunnel syndrome participated in this study. All patients were treated with controlled release tramadol (100 mg every 12 hours) for 10 days. Venous blood (5 mL) was collected in the morning, before treatment and on the 11th day, and stored (-70° C) until analysis. ELISA was used to determine the plasma levels of cytokines (TNF-±, IL-1, IL-6) and receptors sTNF-R1 (R & D Systems). Plasma levels of cytokines of 10 healthy volunteers were also determined. RESULTS: The concentration of TNF-± before (5.8 ± 2.8 pg.mL-¹) was significantly higher than after treatment with tramadol (4.8 ± 2.1 pg.mL-1; p = 0.04, Mann-Whitney test). The levels of IL-1², IL-6, and sTNF-R1 before and after treatment with tramadol showed no significant differences. Plasma levels of TNF-± (healthy individuals: 1.4 ± 0.5; pain patients: 5.8 ± 2.8 pg.mL-1; p = 0.01) and IL-6 (healthy individuals: 1.2 ± 0.8; pain patients: 3.5 ± 2.6 pg.mL-1; p = 0.01) were significantly higher in patients with neuropathic pain, Mann-Whitney Test. CONCLUSIONS: In patients with herniated intervertebral disks and carpal tunnel syndrome, plasma levels of TNF-± and IL-6 were higher than in healthy volunteers, while differences in the concentrations of sTNF-R and IL-1² were not observed. Plasma levels of TNF-±, but not of IL-6, sTNF-R, and IL-1², decreased after treatment with tramadol (100 mg every 12 hours).JUSTIFICATIVA Y OBJETIVOS: Las interleucinas proinflamatorias tienen una función importante en la fisiopatología de los síndromes dolorosos neuropáticos. El objetivo de este estudio, fue evaluar los niveles plasmáticos de interleucinas proinflamatorias antes y después del tratamiento con tramadol en pacientes con hernia de disco y síndrome del túnel del carpo, y compararlos con individuos normales. MÉTODO: Se investigaron 38 pacientes con dolor neuropático por hernia de disco o síndrome del túnel del carpo. Todos los pacientes fueron tratados con tramadol de liberación controlada (100 mg en 12h) durante 10 días. Se realizaron muestras de sangre venosa (5 mL), por la mañana, antes del tratamiento y en el 11º día, y las mismas se almacenaron para ser analizadas (-70ºC). Se utilizaron test enzimáticos ELISA para la dosificación de las interleucinas plasmáticas (TNF-±, IL-1, IL-6) y receptores sTNF-R1, (R & D Systems). Se realizó la dosificación de interleucinas en suero de 10 voluntarios sanos. RESULTADOS: La concentración de TNF-± antes (5,8 ± 2,8 pg.mL-1) fue significativamente mayor que después del tramadol (4,8 ± 2,1 pg.mL-1; p = 0,04, Test de Mann-Whitney). No hubo diferencia significativa de IL-1², IL-6 y sTNF-R1 antes y después del tratamiento. Las concentraciones plasmáticas de TNF-± (sanos: 1,4 ± 0,5; pacientes con dolor: 5,8 ± 2,8 pg.mL-1; p = 0.01) y IL-6 (sanos: 1,2 ± 0,8; pacientes con dolor: 3.5 ± 2,6 pg.mL-1; p = 0,01) fueron significativamente mayores en los pacientes con dolor neuropático que en los voluntarios, test de Mann-Whitney. CONCLUSIONES: En los pacientes con hernia discal y síndrome del túnel del carpo, las concentraciones plasmáticas de TNF-± y IL-6, fueron más elevadas que en los voluntarios sanos, no habiendo ninguna diferencia en las concentraciones de sTNF-R y IL-1². Hubo una reducción de la concentración plasmática de TNF-±; después del tratamiento con tramadol (100 mg en 12h), pero no de IL-6 sTNF-R y IL-1².JUSTIFICATIVA E OBJETIVOS: As citocinas pró-inflamatórias têm função importante na fisiopatologia das síndromes dolorosas neuropáticas. O objetivo desse estudo foi avaliar os níveis plasmáticos de citocinas pró-inflamatórias antes e após o tratamento com tramadol em pacientes com hérnia discal e síndrome do túnel do carpo e compará-los com indivíduos normais. MÉTODO: Investigou-se 38 pacientes com dor neuropática por hérnia discal ou síndrome do túnel do carpo. Todos os pacientes foram tratados com tramadol de liberação controlada (100 mg em 12h) durante 10 dias. Realizaram-se coletas de sangue venoso (5 mL), no período matutino, antes do tratamento e no 11º dia e as amostras foram armazenadas até análise (-70ºC). Foram utilizados testes enzimáticos ELISA para dosagem de citocinas plasmáticas (TNF-±, IL-1, IL-6) e receptores sTNF-R1, (R & D Systems). Realizou-se dosagem de citocinas em soro de 10 voluntários sadios. RESULTADOS: A concentração de TNF-± antes (5,8 ± 2,8 pg.mL-1) foi significativamente maior que após o tramadol (4,8 ± 2,1 pg.mL-1; p = 0,04, Teste Mann-Whitney). Não houve diferença significativa de IL-1², IL-6 e sTNF-R1 antes e após o tratamento. As concentrações plasmáticas de TNF-± (sadios: 1,4 ± 0,5; pacientes com dor: 5,8 ± 2,8 pg.mL-1; p = 0.01) e IL-6 (sadios: 1,2 ± 0,8; pacientes com dor: 3,5 ± 2,6 pg.mL-1; p = 0,01) foram significativamente maiores nos pacientes com dor neuropática que nos voluntários, Teste de Mann-Whitney. CONCLUSÕES: Nos pacientes com hérnia discal e síndrome do túnel do carpo as concentrações plasmáticas de TNF-± e IL-6 foram maiores que em voluntários sadios, não havendo diferença das concentrações de sTNF-R e IL-1². Houve redução da concentração plasmática de TNF-± após tratamento com tramadol (100 mg em 12h), mas não de IL-6, sTNF-R e IL-1².UFBA AnestesiologiaUNIFESPUNIFESP Disciplina de Anestesiologia, Dor e Terapia IntensivaUFBA Laboratório de ImunologiaUFBAUNIFESP, Disciplina de Anestesiologia, Dor e Terapia IntensivaSciELOSociedade Brasileira de AnestesiologiaUFBA AnestesiologiaUniversidade Federal de São Paulo (UNIFESP)UFBA Laboratório de ImunologiaUFBAKraychete, Durval CamposSakata, Rioko Kimiko [UNIFESP]Issy, Adriana Machado [UNIFESP]Bacellar, OlíviaJesus, Rogério SantosCarvalho, Edgar M2015-06-14T13:39:14Z2015-06-14T13:39:14Z2009-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion297-303application/pdfhttp://dx.doi.org/10.1590/S0034-70942009000300004Revista Brasileira de Anestesiologia. Sociedade Brasileira de Anestesiologia, v. 59, n. 3, p. 297-303, 2009.10.1590/S0034-70942009000300004S0034-70942009000300004.pdf0034-7094S0034-70942009000300004http://repositorio.unifesp.br/handle/11600/5073porRevista Brasileira de Anestesiologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-04T22:16:40Zoai:repositorio.unifesp.br/:11600/5073Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-04T22:16:40Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
Proinflammatory cytokines in patients with neuropathic pain treated with Tramadol
Interleucinas proinflamatorias en pacientes con dolor neuropático sometidos a tratamiento con Tramadol
title Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
spellingShingle Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
Kraychete, Durval Campos
ANALGESIC
CYTOKINES
PAIN, neuropathic
ANALGÉSICO
CITOCINAS
DOR, neuropática
title_short Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
title_full Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
title_fullStr Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
title_full_unstemmed Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
title_sort Citocinas pró-inflamatórias em pacientes com dor neuropática submetidos a tratamento com Tramadol
author Kraychete, Durval Campos
author_facet Kraychete, Durval Campos
Sakata, Rioko Kimiko [UNIFESP]
Issy, Adriana Machado [UNIFESP]
Bacellar, Olívia
Jesus, Rogério Santos
Carvalho, Edgar M
author_role author
author2 Sakata, Rioko Kimiko [UNIFESP]
Issy, Adriana Machado [UNIFESP]
Bacellar, Olívia
Jesus, Rogério Santos
Carvalho, Edgar M
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv UFBA Anestesiologia
Universidade Federal de São Paulo (UNIFESP)
UFBA Laboratório de Imunologia
UFBA
dc.contributor.author.fl_str_mv Kraychete, Durval Campos
Sakata, Rioko Kimiko [UNIFESP]
Issy, Adriana Machado [UNIFESP]
Bacellar, Olívia
Jesus, Rogério Santos
Carvalho, Edgar M
dc.subject.por.fl_str_mv ANALGESIC
CYTOKINES
PAIN, neuropathic
ANALGÉSICO
CITOCINAS
DOR, neuropática
topic ANALGESIC
CYTOKINES
PAIN, neuropathic
ANALGÉSICO
CITOCINAS
DOR, neuropática
description BACKGROUND AND METHODS: Proinflammatory cytokines play an important role in the pathophysiology of neuropathic pain syndromes. The objective of this study was to evaluate plasma levels of proinflammatory cytokines before and after treatment with tramadol in patients with herniated intervertebral disks and carpal tunnel syndrome, and to compare them with normal individuals. METHODS: Thirty-eight patients with neuropathic pain secondary to herniated intervertebral disks or carpal tunnel syndrome participated in this study. All patients were treated with controlled release tramadol (100 mg every 12 hours) for 10 days. Venous blood (5 mL) was collected in the morning, before treatment and on the 11th day, and stored (-70° C) until analysis. ELISA was used to determine the plasma levels of cytokines (TNF-±, IL-1, IL-6) and receptors sTNF-R1 (R & D Systems). Plasma levels of cytokines of 10 healthy volunteers were also determined. RESULTS: The concentration of TNF-± before (5.8 ± 2.8 pg.mL-¹) was significantly higher than after treatment with tramadol (4.8 ± 2.1 pg.mL-1; p = 0.04, Mann-Whitney test). The levels of IL-1², IL-6, and sTNF-R1 before and after treatment with tramadol showed no significant differences. Plasma levels of TNF-± (healthy individuals: 1.4 ± 0.5; pain patients: 5.8 ± 2.8 pg.mL-1; p = 0.01) and IL-6 (healthy individuals: 1.2 ± 0.8; pain patients: 3.5 ± 2.6 pg.mL-1; p = 0.01) were significantly higher in patients with neuropathic pain, Mann-Whitney Test. CONCLUSIONS: In patients with herniated intervertebral disks and carpal tunnel syndrome, plasma levels of TNF-± and IL-6 were higher than in healthy volunteers, while differences in the concentrations of sTNF-R and IL-1² were not observed. Plasma levels of TNF-±, but not of IL-6, sTNF-R, and IL-1², decreased after treatment with tramadol (100 mg every 12 hours).
publishDate 2009
dc.date.none.fl_str_mv 2009-06-01
2015-06-14T13:39:14Z
2015-06-14T13:39:14Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0034-70942009000300004
Revista Brasileira de Anestesiologia. Sociedade Brasileira de Anestesiologia, v. 59, n. 3, p. 297-303, 2009.
10.1590/S0034-70942009000300004
S0034-70942009000300004.pdf
0034-7094
S0034-70942009000300004
http://repositorio.unifesp.br/handle/11600/5073
url http://dx.doi.org/10.1590/S0034-70942009000300004
http://repositorio.unifesp.br/handle/11600/5073
identifier_str_mv Revista Brasileira de Anestesiologia. Sociedade Brasileira de Anestesiologia, v. 59, n. 3, p. 297-303, 2009.
10.1590/S0034-70942009000300004
S0034-70942009000300004.pdf
0034-7094
S0034-70942009000300004
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Revista Brasileira de Anestesiologia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 297-303
application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Anestesiologia
publisher.none.fl_str_mv Sociedade Brasileira de Anestesiologia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268272538812416